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Extracellular vesicle cross-talk between
pulmonary artery smooth muscle cells and
endothelium during excessive TGF-β
signalling: implications for PAH vascular
remodelling
Fernando de la Cuesta1, Ilaria Passalacqua1, Julie Rodor1, Raghu Bhushan1,2, Laura Denby1 and Andrew H. Baker1*
Abstract
Background: Excessive TGF-β signalling has been shown to underlie pulmonary hypertension (PAH). Human
pulmonary artery smooth muscle cells (HPASMCs) can release extracellular vesicles (EVs) but their contents and
significance have not yet been studied. Here, we aimed to analyse the contents and biological relevance of
HPASMC-EVs and their transport to human pulmonary arterial endothelial cells (HPAECs), as well as the potential
alteration of these under pathological conditions.
Methods: We used low-input RNA-Seq to analyse the RNA cargoes sorted into released HPASMC-EVs under basal
conditions. We additionally analysed the effects of excessive TGF-β signalling, using TGF-β1 and BMP4, in the
transcriptome of HPASMCs and their EVs. We then, for the first time, optimised Cre-loxP technology for its use with
primary cells in vitro, directly visualising HPASMC-to-HPAEC communication and protein markers on cells taking up
EVs. Furthermore we could analyse alteration of this transport with excessive TGF-β signalling, as well as by other
cytokines involved in PAH: IL-1β, TNF-α and VEGFA.
Results: We were able to detect transcripts from 2417 genes in HPASMC-EVs. Surprisingly, among the 759 enriched
in HPASMC-EVs compared to their donor cells, we found Zeb1 and 2 TGF-β superfamily ligands, GDF11 and TGF-β3.
Moreover, we identified 90 genes differentially expressed in EVs from cells treated with TGF-β1 compared to EVs in
basal conditions, including a subset involved in actin and ECM remodelling, among which were bHLHE40 and
palladin. Finally, using Cre-loxP technology we showed cell-to-cell transfer and translation of HPASMC-EV Cre mRNA
from HPASMC to HPAECs, effectively evidencing communication via EVs. Furthermore, we found increased number
of smooth-muscle actin positive cells on HPAECs that took up HPASMC-EVs. The uptake and translation of mRNA
was also higher in activated HPAECs, when stimulated with TGF-β1 or IL-1β.
(Continued on next page)
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: Andy.Baker@ed.ac.uk
1Centre for Cardiovascular Science, Queen’s Medical Research Institute,
University of Edinburgh, 47 Little France Crescent, EH16 4TJ, Edinburgh EH16
4TJ, UK
Full list of author information is available at the end of the article
de la Cuesta et al. Cell Communication and Signaling          (2019) 17:143 
https://doi.org/10.1186/s12964-019-0449-9
(Continued from previous page)
Conclusions: HPASMC-EVs are enriched in RNA transcripts that encode genes that could contribute to vascular
remodelling and EndoMT during development and PAH, and TGF-β1 up-regulates some that could enhance this
effects. These EVs are functionally transported, increasingly taken up by activated HPAECs and contribute to
EndoMT, suggesting a potential effect of HPASMC-EVs in TGF-β signalling and other related processes during PAH
development.
Keywords: Cell communication, Comparative transcriptomics, Cre-loxP, Extracellular vesicles, In vitro imaging,
Pulmonary artery, RNA-Seq, TGF-β
Background
Pulmonary arterial hypertension (PAH) is a rare disease,
with an estimated prevalence which ranges from 10 to
52 cases per million [1]. The development of PAH is as-
sociated with aggravation of clinical symptoms and in-
creased mortality [2]. Alteration of TGF-β signalling is a
major cause underlying PAH, as mutations in receptors
in the TGF-β superfamily are responsible for almost all
familial PAH, with BMPR2 alterations being the most
prominent [3]. Although TGF-β and BMP ligands stimu-
late opposing signalling pathways [3], the regulation of
this signalling is complex frequently displaying cross-
stimulation [4, 5]. The imbalance of this signalling is the
main trigger for the altered phenotype of pulmonary
artery cells during PAH [5, 6].
Extracellular vesicles (EVs) are essential mediators of cell-
to-cell communication [7, 8]. These vesicles contain RNA,
lipids, proteins and fragments of DNA [7]. EVs can act as
positive or negative modulators of cardiovascular diseases
depending on the type and state of the cells from which
they can originate. For example, EVs contribute to athero-
sclerosis progression and plaque rupture promoting micro-
calcification [9, 10] and, in contrast, certain EVs have
beneficial effects on vascular function and endothelial re-
generation [11, 12]. In the context of pulmonary function
and disease, cross-talk occurs between the two major cell
types: endothelial and smooth muscle cells [5]. While trans-
port from human pulmonary arterial endothelial cells
(HPAEC) to human pulmonary arterial smooth muscle
cells (HPASMCs) has been studied in PAH [13–17], the
relevance of HPASMC-to-HPAEC communication remains
unclear. Recently, we showed EV-mediated transfer of miR-
143 from HPASMC to HPAECs leads to migration and
angiogenesis [18]. We therefore hypothesised that imaging
HPASMC-EVs-mediated transfer and quantification of
their cargo might unveil novel insights through which
HPASMCs and HPAECs could impact PAH (Fig. 1 a).
A novel methodology based on Cre-loxP has been re-
cently shown to monitor EV-mediated transfer of mRNA
from donor to recipient cells [19, 20]. This methodology
was developed to visualize EVs derived from cancer cells
and successfully used with progenitor cells from mouse
retina [21]. Here, we attempted to adapt the current
technology to allow efficient Cre-induced recombination
in primary vascular cell:cell communication. Here, we
show that HPASMC-EVs are enriched in Zeb1 and the
TGF-β superfamily ligands GDF11 and TGF-β3. Besides,
we found an upregulation of palladin and bHLHE40
with TGF-β1-mediated pathogenic stimulation and pro-
vide essential new evidence of a functional EV-mediated
transport of mRNA from HPASMC-to-HPAEC and
showing increase uptake and translation in activated
HPAECs.
Methods
An extended version of the Methods section can be found
in Supplementary Material.
Cell culture
Cultures of HPASMCs and HPAECs have been described
previously [18]. Stimulation of HPASMCs with TGF-β1
(10 ng/ml), BMP4 (10 ng/ml) and IL-1β (10 ng/ml) for 48 h
renewing stimuli every 24 h. FBS used was depleted of EVs
by overnight ultracentrifugation at 100,000·g.
Isolation of EVs
Supernatants were centrifuged at 2000·g for 10′ at 4 °C
to remove dead cells. Then EVs were isolated by means
of two steps of ultracentrifugation at 100,000·g for 1 h at
4 °C in a Sorvall WX+ Ultracentrifuge using a TH-641
Swinging Bucket rotor (Thermo Fischer Scientific).
Western blot
SDS-PAGE and transfer onto nitrocellulose mem-
branes were performed in a Bolt Mini Gel Tank elec-
trophoresis unit (Thermo Fisher Scientific). Primary
antibodies used were mouse monoclonal to CD63,
ab59479; rabbit polyclonal to Histone 3, ab70550,
from Abcam; goat polyclonal to Zeb1, sc-10,572, from
Santa Cruz Biotechnology; and mouse monoclonal to
GAPDH, D4C6R, and rabbit monoclonal to GAPDH,
14C10 from Cell Signaling Technology. Secondary
antibodies used were from LI-COR: IRDye 800CW
goat anti-mouse, IRDye 680RD goat anti-rabbit, IRDye
680RD goat anti-mouse and IRDye 800CW goat anti-
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rabbit. Detection was performed in an Odissey im-
aging system (LI-COR).
Nanoparticle tracking analysis (NTA)
The pellet from EVs isolated by ultracentrifugation was
suspended in PBS and visualised in a NanoSight LM14
instrument (Malvern Panalytical). An amount of 3–5
videos of 60 s were acquired per sample and only in-
cluded if exceeding 500 particle tracks. EVs/ml were cal-
culated as average of these technical replicates and
normalised to the number of cells counted at endpoint
to calculate EVs/cell.
RNA-Seq
HPASMCs and EVs from supernatants were collected
and RNA was extracted with miRNeasy kit (Qiagen),
quantified using Qubit technology (Thermo Fisher
Scientific) and samples’ quality was checked in a 2100
Bioanalyzer (Agilent, Additional file 1: Fig. S1B). The
total amount of RNA obtained from EVs was 9 ng.
Thus, library was prepared with SMARTer Low-Input
Strand-Specific Total RNA-Seq for Illumina (Takara,
Clontech). NGS was performed by BGI Tech Solutions
on a HiSeq 4000 (Illumina). The sequencing quality
was assessed using FastQC. Number of paired-end
reads were between 5.5 × 107–6 × 107 for all samples
(Additional file 1: Fig. S1 C). Read mapping to the hu-
man genome was carried out with STAR [22] using
GENCODE GRCh38 genome sequence and GEN-
CODE v26 transcriptome annotation. To study differ-
ential expression at the cell level, we quantified gene
expression using HTSeq-count [23], based on the
mapped reads. As expected with low-input library se-
quencing [24], we noted a high level of duplication, in
particular for EV samples. To study the transcriptome
of EVs, we decided to add a step to remove duplicated
reads before the HTSeq-count quantification analysis.
The removal of duplicates was done using the
markdup option from SAMtools [25]. RNA-Seq data
has been submitted to NCBI's Gene Expression Omni-
bus and are accessible through GEO Series accession
number GSE131998. The gene ontology analyses was
done using topGO on differential expressed genes over
a background of expressed genes [26]. Interaction ana-
lyses were performed with String Database v10.5. The
interactions calculated by the software include direct
(physical) and indirect (functional) associations and
are based on genomic context predictions, high-
throughput lab experiments, automated text mining
and database searching. The network links are not ul-
timately representative of functional relationships be-
tween nodes but rather show a probability of
interaction based on the aforementioned calculations.
Gene expression quantitative real time-PCR (qRT-PCR)
For gene expression analysis, cDNA for mRNA analysis
was obtained from total RNA using the RevertAid First
Strand cDNA Synthesis Kit (Thermo Fisher Scientific).
qRT-PCR was performed using TaqMan primers or
Power SYBR green (Life Technologies) with custom PCR
primers (Eurofins MWG, primer sequences can be found
in Additional file 7: Table S6). Ubiquitin C (UBC) or
GAPDH were selected as housekeeping genes due to its
stability across all groups studied, as found on the RNA-
Seq differential analyses.
Immunocytochemistry (ICC)
Cells were fixed, permeabilized and incubated with the
following primary antibodies: mouse monoclonal to
CD9, sc-59,140; mouse monoclonal to CD81, sc-166,029;
mouse monoclonal to CD63, ab59479, rabbit polyclonal
to BMP11 (=GDF11), ab220951, rabbit polyclonal to
TGF-β3, ab15537, from Abcam; and rabbit polyclonal to
Zeb1, HPA027524, from Sigma-Aldrich. Phalloidin-
iFluor 488 (Abcam) was used to counterstain the cell’s
actin cytoskeleton. The secondary antibodies used were:
goat anti-rabbit Alexa Fluor 594 (Abcam) and goat anti-
mouse Alexa Fluor 647 (Invitrogen). Nuclei were stained
with DAPI. Cells were visualized in a TCS SP8 confocal
microscope (Leica).
PKH67 labelling of EVs
EVs were labelled with PKH67 dye for 30 s and then
quenched with 1% FBS before amply diluting in FBS-free
MEM followed by ultracentrifugation at 100,000×g. The
pellet was suspended in FBS-free MEM and EVs/ml
were calculated by NTA. 5 × 103 HPASMC-EVs/cell
were used to treat HPAECs in culture for 20 h. Ultracen-
trifugation and addition to HPAECs of a negative con-
trol of PKH67 dye alone was carried out in parallel as to
(See figure on previous page.)
Fig. 1 Characterisation of EVs released by HPASMC in vitro. a, Schematic representation of the approach used to analyse EVs-mediated HPASMC-
to-HPAECs communication. b, Quantification of the downstream gene Serpine1 by qRT-PCR shows specific activation with TGF-β1. Id1 was highly
activated by BMP4 and mildly by TGF-β1 due to these signalling pathways´ crosstalk, as expected. c, Immunocytochemistry showing CD63+ EVs
from HPASMCs in cell culture (representative image from n = 4 independent experiments). d, Identity of HPASMC-EVs isolated by
ultracentrifugation was confirmed by expression of CD63 marker, as opposed to their donor HPASMCs. Histone 3 used as a control for cell
contamination was only detectable in HPASMCs. GAPDH was used as HPASMC loading control. e, The HPASMC-EVs isolated were analysed by
Nano Tracking Analysis (NTA) which showed EVs ranging 80–500 nm with a highest peak at 150 nm
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assure that aggregated dye or stained protein were not
the cause for the observed uptake.
Production of lentiviral vectors
Lentiviral vectors were produced by triple transient
transfection of HEK293T cells as previously described [27].
Lentiviral titres were ascertained by TaqMan quantitative
real-time PCR (qRT-PCR) using the primer/probe se-
quences described on Additional file 7: Table S6. A Cre
recombinase lentivirus (LV-Cre) was produced with a LV-
CMV-nlsCre plasmid (Plasmid #12265, Addgene: https://
www.addgene.org/). A reporter lentivirus (LV-Rep) was
generated from the plasmid pLV.CMV.MCS.LoxP-DsRed-
Loxp-eGFP, which was a kind gift from Prof. Jacco Van
Rheenen, Hubrecht Institute. An empty lentiviral vector
was also produced to use as Null control for LV-Cre
transduction.
Primary cell Cre-loxP method
Donor HPASMCs were transduced with LV- Cre and re-
cipient HPAECs with LV-Rep. HPASMCs Cre + and
HPAECs Rep+ were co-cultured for 7 days using a Cre+:
Rep+ ratio of 3 as to enhance EV transfer. Cre-mediated
recombination was calculated by the %eGFP+/DsRed+
ratio, as measured by FACS. The markers smooth-
muscle actin (SMA) and collagen III were quantified at
endpoint (7 days) using the antibodies mouse monoclo-
nal SMA-405 (IC1420V, R&D); and rabbit monoclonal
collagen III (ab184993, Abcam) with a secondary goat
anti-rabbit Alexa Fluor 647 (Invitrogen), after fixing with
2% paraformaldehyde and permeabilising with 0.1% Tri-
ton X-100. Stimulation of co-cultures with TGF-β1 (5
ng/ml), BMP4 (5 ng/ml), IL-1β (5 ng/ml), TNF-α (1 ng/
ml) and VEGFA (20 ng/ml) during the 7 days protocol
was renewed every 48 h.
Statistical analysis
RNA-Seq differential expression analysis was performed
using DESeq2 on the raw read count. Sample clustering
was evaluated using the Principal component analysis
(PCA) tool available in DESeq2 [28] on the regularized
log transformed data. The correlation between the Log
fold chance in EV and the Log fold change in Cells after
TGF-β1 treatment was assessed using the Pearson cor-
relation test. For the gene ontology analyses, Fisher’s
exact test was used to calculate the p-values.
Data in graphs are given as mean ± standard error
mean (SEM). Comparisons between 2 groups were ana-
lysed using 2-tailed unpaired Student’s t test. All statis-
tical analyses of qRT-PCR data were performed on the
dCt scale whereas for graphical representation RQ ±
SEM was used. For validation analyses of RNA-Seq data
performed by qRT-PCR a 1-tailed unpaired Student’s t
test was used. No evidence of unequal variances across
groups was found for any of analyses of the dCt scale
data using Levene’s test prior to statistical analysis. Stat-
istical significance is denoted by a P value of less than
0.05 with 3 different categories represented: *P ≤ 0.05,
**P ≤ 0.01, ***P ≤ 0.001.
Results
Characterisation of HPASMC-derived EVs
We have investigated disease-associated signalling path-
ways aiming to characterise its potential impact in PAH
using cultures of HPASMCs stimulated with or without
TGF-β1 or BMP4 (Additional file 1: Fig. S1A). To con-
firm the activation of associated pathways, we quantified
the downstream genes Serpine1 and Id1 (Fig. 1b). We
then investigated whether HPASMCs contain EVs under
physiological conditions using the EV markers CD9,
CD81 and CD63. Staining for CD9 or CD81 was mainly
present on plasma membrane (Additional file 1: Fig.
S2A), while CD63 EV-like structures showing positive
staining to CD63 were found within the cytoplasm and
membrane of HPASMCs (Fig. 1c). This is consistent
with the main subcellular location found in Human Pro-
tein Atlas (vesicle for CD63, membrane for both CD9
and CD81, Additional file 1: Fig. S2B) and for this reason
we used CD63 marker for further immunocytochemical
(ICC) experiments. HPASMC-derived EVs were effi-
ciently isolated by ultracentrifugation, as verified by pro-
tein expression of CD63 and His3 as negative marker
(Fig. 1d). NTA further confirmed the presence of EVs,
which ranged between 80 and 500 nm (Fig. 1e). There-
fore, we efficiently isolated HPASMC-EVs for further
molecular analysis.
HPASMC- derived EVs show a specific transcriptome and
are enriched in TGF- β superfamily ligands GDF11, TGF-β3
and transcription factor Zeb1
In order to analyse the RNA diversity in HPASMCs and
their released EVs we used low-input RNA-Seq. We de-
tected transcripts from 2417 genes from HPASMC-EVs
and 13,867 in cellular RNA (Fig. 2a). We sought to
examine differences in transcriptome of HPASMCs and
EVs to determine RNAs specifically sorted into EVs. For
that purpose, an enrichment analysis was performed
consisting of the quantification of cargoes with higher
expression in EVs compared to HPASMCs. 759 RNAs
were found significantly enriched in EVs (Additional file
2: Table S1). This implies that EVs contain a specific
transcriptome. The majority of RNAs enriched in EVs
are protein-coding but there is an overrepresentation of
pseudogenes (Fig. 2a). Among the cargoes enriched in
healthy HPASMC-EVs, we found GDF11, TGF-β3 and
Zeb1 (Fig. 2b). This was validated by qRT-PCR in 3 in-
dependent biological replicates (Fig. 2c). We then exam-
ined protein levels by ICC on HPASMCs studying co-
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localization with CD63. In the case of GDF11 and TGF-
β3 co-localization with CD63 was negative, with GDF11
being very minimally expressed on the protein level
(Additional file 1: Fig. S3A and S2B). Remarkably, Zeb1
protein was found co-localized with CD63 within cyto-
plasm (Fig. 2d). Moreover, western blot analysis showed
a specific expression of Zeb1 protein in EVs, being al-
most undetectable in HPASMCs, corroborating that the
enrichment is occurring at both mRNA and protein
levels. The very low levels of Zeb1 in HPASMCs ob-
served by western blot are surprising given the results
observed by ICC (Fig. 2d). The reasons for this might be
that the extraction of nuclear proteins is not as efficient
as the one from cytoplasmic ones and that vesicles aris-
ing from membrane might be lost during washes while
preparing cells for extraction.
The results obtained show a specific transcriptome of
HPASMC-EVs, which are enriched in TGF-β superfam-
ily ligands and Zeb1 in basal conditions.
Excessive TGF-β signalling promotes switch of HPASMCs
towards a pro-fibrotic phenotype and alters EVs’ cargo
We next sought to quantify the effect of pathogenic stimuli
on HPASMC transcriptome and EVs’ cargo. HPASMCs
were treated with or without TGF-β1 or BMP4. At the cel-
lular level, PCA showed a clear separation of the 3 groups
and the major variance associated with TGF-β1 treatment
(Fig. 3a). Within HPASMCs TGF-β1 treatment resulted in
1484 differential transcripts and BMP4 in 608 (Additional
file 3: Table S2). Classical downstream genes were activated
with each treatment (Fig. 3b). TGF-β1 induced Serpine 1
and 2, TGF-β1 and TGF-β2, and several collagen variants.
BMP4 activated Id1 and Id3, GATA2 [29], and showed a
much lower up-regulation of collagens. GO enrichment ana-
lysis of TGF-β1 differential genes highlighted some bio-
logical processes relevant to PAH such as cell migration,
proliferation and inflammation (Fig. 3c and Additional file 4:
Table S3). Interestingly, cell communication was signifi-
cantly represented and could suggest an activation of cross-
talk pathways i.e. EV-mediated communication, leading to
study EVs more deeply. Pathway analysis reinforced aug-
mented fibrosis signalling with TGF-β1 and showed down-
regulation of some inflammatory pathways (Fig. 3d)
including interleukins, TNF-α receptors and CXCLs (Fig.
3e). The latter was also observed in BMP4 treated HPASMC
although to a lower extent (Fig. 3e).
We next compared the transcriptome of EVs in the
three different conditions. EVs from TGF-β1 treated
cells showed greater differences compared to control
than BMP4, as shown by PCA (Fig. 4a), mirroring what
we observed in the cells (Fig. 3a). We found 90 differen-
tial RNAs in TGF-β1 EVs, whereas only 5 in BMP4
(Additional file 5: Table S4). For this reason we then fo-
cused on TGF-β1 EVs for subsequent analysis. To ex-
plore whether levels of expression in EVs reflect gene
expression in TGF-β1 treated cells, we performed a cor-
relation analysis of read numbers. The analysis showed a
significant correlation (R = 0.5628, p value = 1.084·10− 8;
Fig. 4b). GO enrichment analysis highlighted that the
differential RNAs found in TGF-β1 EVs were related to
cell differentiation, migration and response to wounding
(Fig. 4c and Additional file 6: Table S5) and interaction
analysis showed a cluster of RNAs related to actin and
ECM remodelling (Fig. 4d). Among these RNAs, we vali-
dated palladin and bHLHE40 by qRT-PCR in 3 inde-
pendent biological replicates (Fig. 4e). Thus, HPASMCs
change their phenotype in response to excessive TGF-β
signalling and this results in a reflection in the levels of
some RNAs in EVs, including upregulation of palladin
and bHLHE40.
EV-mediated transfer of mRNA from HPASMCs is
translated into protein in HPAECs and induces
overexpression of smooth-muscle-actin
Since EVs from HPASMC in biological and pathological
conditions contain RNA with the potential to affect
endothelial cell biology, we aimed to confirm their up-
take by HPAECs. First, HPASMC-EVs were labelled with
PKH67 dye and added to HPAECs in culture. After 20 h,
many HPAECs presented green fluorescent particles in
their cell membrane (Fig. 5a), confirming the transfer of
EVs.
To prove functional transfer of the RNAs contained in
EVs, we optimised the recently described Cre-loxP method
[20] to make it for the first time applicable to vascular pri-
mary cell model systems. For that purpose, the vector
chosen to generate Cre+ donor cells was a lentivirus (LV-
nlsCre) due to its efficient gene delivery to primary vascular
(See figure on previous page.)
Fig. 2 HPASMC-EVs show a specific transcriptome and are enriched in Zeb1, GDF11 and TGF-β3. Data from the low-input RNA-Seq was analysed
to examine the cargoes sorted into HPASMC-EVs. Enrichment analysis was performed consisting in the quantification of cargoes with higher
expression in EVs compared to their donor HPASMCs (pvalue < 0.05 and FC > 2). a, Proportion of coding/non-coding RNAs detected in HPASMC
and their EVs. b, Volcano plot showing the transcripts depleted or enriched in EVs compared to donor HPASMCs (pvalue < 0.05 and FC < − 2 or
FC > 2). Among the enriched we found: Zeb1, GDF11 and TGF-β3. c, Validation by qRT-PCR of the enrichment of GDF11, TGF-β3 and Zeb1 in
HPASMC-EVs (n = 3 biological replicates, data are presented as mean ± SEM. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 (Student’s t-test). d,
Immunocytochemistry of Zeb1 and CD63 proteins showing co-localisation within the cytoplasm of HPASMCs. e, Western Blot showing a specific
expression of Zeb1 protein in EVs. Scale bars = 10 μm. Protein interaction analyses were performed with STRING and GO enrichment using DAVID
software. PCA = principal component analysis, GO = Gene Ontology
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Fig. 3 Stimulation of TGF-β signalling triggers fibrotic phenotype and downregulates inflammatory pathways on HPASMCs. a, Control, TGF-β1-
treated and BMP4-treated HPASMCs were analysed by RNA-Seq. PCA analysis of HPASMCs showed a greater effect of TGF-β1 than BMP4, as these
HPASMCs were separated from the rest by the first principal component, accounting for 69% of the variance. b, Heatmap showing the activation
of specific downstream markers of TGF-β1 and BMP4 pathways. c, GO analysis for biological process of the differential transcripts in TGF-β1-
treated HPASMCs provided significant terms relevant to PAH: cell migration (yellow), proliferation (brown) and inflammation (grey), as well as with
cell communication (pink). d, Interactome analysis of the top differential RNAs in TGF-β1-treated HPASMCs. Most relevant clusters are highlighted:
Inflammation, ECM remodelling/cell adhesion, serotonin signalling and signal transduction. e, Heatmap showing the inflammatory markers
downregulated in response to activation of TGF-β signalling in HPASMCs. Treatment of HPASMC with TGF-β1 or BMP4 (both 10 ng/ml) was
performed for 48 h and renewed every 24 h. Protein interaction analyses were performed with STRING and GO enrichment using DAVID software.
PCA = principal component analysis, GO = Gene Ontology
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cells (Fig. 5b). Following LV-mediated infection of
HPASMC, qRT-PCR showed a clear presence of Cre
mRNA in HPASMC Cre+-EVs (Fig. 5c), showing efficient
loading into EVs. HPASMC Cre+ and HPAECs Rep+ were
co-cultured. We observed significant Cre-mediated recom-
bination compared to control cultures from HPASMC
Null: HPAECs Rep+ and HPAECs Rep+ cells alone (Fig.
5d). This proves transfer of Cre mRNA from HPASMC to
Fig. 4 EVs from TGF-β1 treated HPASMCs reflect changes in gene expression and carry greater amounts of palladin and bHLHE40. a, Data from
the low-input RNA-Seq was analysed to find differentially expressed RNAs present in EVs from HAPSMCs treated with TGF-β1 and BMP4. PCA
showed EVs from TGF-β1 treated cells being further separated from controls than those from BMP4-EVs, in a similar extent to their donor cells. b,
Representation of fold change in TGF-β1 treated HAPSMCs and their EVs showing correlation of the alterations found on differential transcripts. c,
GO analysis for biological processes performed with the differential transcripts found in EVs from TGF-β1 treated HAPSMCs. d, Protein interaction
analysis of the RNAs differentially expressed in EVs from TGF-β1-treated HPASMCs compared to control EVs. A node involved in actin and ECM
remodelling has been underlined. Position of palladin in this node is highlighted. e, Validation by qRT-PCR of the upregulation of palladin and
bHLH40 in HPASMCs and their EVs after 48 h TGF-β1 stimulation (n = 3 biological replicates). Data are presented as mean ± SEM. *P ≤ 0.05, **P≤
0.01, ***P ≤ 0.001 (Student’s t-test). Treatment of HPASMC with TGF-β1 (10 ng/ml) was performed for 48 h and renewed every 24 h. Protein
interaction analyses were performed with STRING and GO enrichment using DAVID software. PCA = principal component analysis,
GO = Gene Ontology
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HPAEC and translation into protein in the recipient
HPAECs. Two markers related to EndoMT and vascular
remodelling were analysed on HPAECs Rep+ after 7 days
co-culture with HPASMCs Cre+, SMA and collagen III.
We observed increase of SMA+ cells (13-fold, pvalue =
0.016) on HPAECs that took up HPASMC-EVs after co-
culture (eGFP+), compared to those that did not (DSRed+
eGFP−), showing induction of the expression of this
EndoMT marker by HPASMC-EVs. Collagen III showed a
moderate close-to-significance (1.06-fold, pvalue = 0.086)
increase on positive HPAECs.
EV-mediated transfer of mRNA from HPASMC to HPAEC
in vitro is enhanced by TGF-β1 and IL-1β
Using this methodology, we next investigated whether
EV-mediated communication from HPASMC-to-HPAEC
was altered by excessive TGF-β signalling, as well as by
other cytokines involved in PAH including IL-1β, TNF-α
and VEGFA, which have been found increased in the
serum of PAH patients [30, 31]. Results showed significant
variation in transfer of EV-RNA with TGF-β1 and IL-1β,
whereas BMP4, TNF-α and VEGFA showed no differ-
ences (Fig. 6a and b). NTA analysis of EVs released by
HPASMCs upon stimulation with TGF-β1 and IL-1β
showed no significant alteration of EVs/cell in the condi-
tioned media (Fig. 6c). Hence, TGF-β1 and IL-1β enhance
transport of EVs from HPASMCs to HPAEC but do not
increase release by the former, which implies that the ob-
served enhanced communication is mainly due to aug-
mented uptake by activated HPAECs.
Discussion
In this study, we investigated the RNA diversity in EVs
from healthy HPASMCs and its variation in 2 different
conditions of altered TGF-β signalling. Untreated EVs
showed a differential transcriptome of that of HPASMCs.
Among the enriched cargoes in untreated EVs we found
GDF11 and TGF-β3, both ligands of the TGF-β superfam-
ily, and Zeb1. Besides, we found an upregulation of
palladin and bHLHE40 with TGF-β1. Using a novel pri-
mary cell suitable Cre-loxP method we demonstrated
functional EV-mediated transport of mRNA from
HPASMC-to-HPAEC in normal conditions and an en-
hanced uptake by activated HPAECs.
Our study shows the potential for these EVs to have a
paracrine effect on TGF-β signalling and hence play a
relevant role in vascular physiology. Furthermore, they
could also contribute to PAH development since exces-
sive TGF-β stimulation has been proven to underlie this
pathology [2]. TGF-β3 has been previously found to be
enriched in EVs from mesenchymal stem cells (MSCs)
[32]. We then analysed the protein expression of both
TGF-β ligands, finding that this enrichment was only
evident for the mRNA as CD63+ EVs didn’t co-localize
with both cargoes at the protein level.
The transcription factor Zeb1, a well-known gate-
keeper for EMT and EndoMT [33], was also enriched in
HPASMC-EVs. This was suggesting a potential contri-
bution of HPASMC-EVs in EndoMT processes taking
place in neighbouring HPAECs. Although the presence
of Zeb1 mRNA has been also described in exosomes de-
rived from mesenchymal non-small cell lung cancer cells
[34], this is the first time the enrichment of this tran-
scription factor in HPASMC-EVs has been demon-
strated and puts these EVs in the spotlight as potential
contributors for EndoMT, thus they might play an im-
portant role in vascular remodelling occurring during
development. This is reinforced by co-localization with
CD63 in HPASMCs and western blot analysis showing a
specific expression of Zeb1 protein in EVs, which im-
plies enrichment in EVs at both mRNA and protein
levels. The localisation of mRNA and protein from the
same gene in the vesicle is unexpected, since the mecha-
nisms of sorting into EVs will be different for both types
of macromolecules. In this respect, the enrichment of
Zeb1 RNA and protein in EVs is quite remarkable. Even
under basal conditions, HPASMCs show enrichment in
many different RNA species, a number of which are
(See figure on previous page.)
Fig. 5 EV-mediated transfer of mRNA from HPASMC to HPAECs results in protein translation in vitro. a, HPAECs in culture were treated 20 h with
5 × 103 HPASMC-EVs/cell labelled with PKH67. Then, immunocytochemistry for CD31 was carried out. Many CD31+ HPAECs were shown to bind
and take up HPASMC-EVs. b, Optimised Cre-loxP method for monitoring EV transfer for the first time applicable to in vitro primary cells with
limited lifespan. A lentiviral vector was used to transduce donor cells (HPASMC) assuring high efficiency of transgene expression. Recipient cells
(HPAECs) were transduced with the original lentiviral reporter construct at a low MOI = 0.1 to avoid background recombination and sorted in a
FACS Aria Fusion sorter (BD Biosciences) to provide 100% Reporter+ cells. c, Amount of Cre mRNA quantified by qRT-PCR on EVs from HPASMC
Cre+ and compared to control HPASMCs. Average fold-change above 2 × 105 showed clear induction of the sorting of Cre mRNA into HPASMC-
EVs. d, Co-cultures of HPASMC Cre+ and HPAECs Rep+ showed specific recombination on HPAECs switching into green fluorescence, as opposed
to negative control HPASMC Null+: HPAECs Rep+ cells co-cultures. e, Quantification of Cre-induced recombination by FACS showed significant
increase in co-cultures as opposed to control (HPAEC Rep+ only) and HPASMC Null+: HPAECs Rep+ cells co-cultures. f, The markers SMA and
collagen III were quantified by flow cytometry at day 7 after HPASMC Cre+: HPAECs Rep+ co-culture. Differential analysis of HPAECs that take up
HPASMC-EVs (eGFP+) vs. HPAECs that do not (DsRed+ eGFP−) showed a significant increase of SMA (13-fold, pvalue = 0.016) in eGFP+ cells and a
mild close-to-significant increase of collagen III (1.06-fold, pvalue = 0.087). Data are presented as mean ± SEM. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001
(Student’s t-test). All procedures were carried out with n = 3 biological replicates. Scale bars 4x = 300 μm; 10x = 120 μm; 20x = 60 μm. SMA:
smooth-muscle actin.
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Fig. 6 (See legend on next page.)
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known mediators of important biological effect affecting
the endothelium.
Next, we studied the molecular effects of TGF-β
modulation in both HPASMCs and their EVs. Many
extracellular matrix genes were upregulated in
HPASMCs upon stimulation supporting a switch into
a pro-fibrotic phenotype. Interestingly, a considerable
amount of inflammatory genes were found downregu-
lated. This for the first time reveals that excessive
TGF-β signalling promotes fibrosis without activating
inflammatory pathways in HPASMCs. It is well-known
that there is a highly inflammatory milieu in the pul-
monary artery during PAH coming from infiltrated
lymphocytes and other resident cell types [35]. It is
therefore likely that other stimuli present in the vessel
are responsible for the inflammatory response of
HPASMC during PAH.
Then we compared the cargoes altered in HPASMCs-
EVs in response to TGF-β stimulation. Upregulation of
transcripts involved in actin and ECM remodelling by
TGF-β1 was found in EVs according to the GO enrich-
ment analysis. Thus, these EVs show a potential to acti-
vate and induce phenotypic changes on HPAECs during
PAH development if uptake was to be proven. Among
these differential RNAs from TGF-β1-EVs treated
HPASMCs, palladin and bHLHE40 (also called Dec1),
which have been shown to promote a malignant pro-
proliferative phenotype in cancer cells by promoting
epithelial-to-mesenchymal transition [36–39], were fur-
ther validated. The gene bHLHE40 is besides a down-
stream target of TGF-β signalling [40].
Since our transcriptomic analyses have suggested that
HPASMC-EVs could have the potential to affect HPAECs
in physiological and pathological conditions, we aimed to
study the potential ability of these EVs to transfer mRNA
cargo to neighbouring HPAEC. To do so, we developed a
novel Cre-loxP methodology suitable to primary cells with
limited lifespan in vitro. This paves the way for future
studies using our refined system in cell cultures requiring
a shorter procedure as well as offering results in half the
time in all cases. With our improved method, we have
been able to visualise for the first time functional commu-
nication from HPASMC-to-HPAEC in vitro, demonstrat-
ing transfer and translation of Cre mRNA through EVs,
resulting in protein expression in recipient HPAECs.
Thus, mRNAs transported to HPAECs may lead to func-
tional activation. To test this, we analysed two markers of
EndoMT and vascular remodelling, smooth-muscle actin
and collagen III, on HPAECs Rep+ after 7 days co-culture
with HPASMCs Cre+. We observed a dramatic increase of
SMA-positive HPAECs (13-fold) on cells that took up
HPASMC-EVs after co-culture, compared to those that
did not. This result evidences that HPASMC-EVs pro-
mote a phenotypic switch of HPAECs, possibly contribut-
ing to induce EndoMT. We also analysed collagen III, as a
marker of fibrosis, which is also increased in EndoMT. In
this case the levels observed in HPAECs after co-culture
with HPASMCs were high, regardless of the former hav-
ing taken up EVs. Probably due to this, only a moderate
close-to-significance (pvalue = 0.086) increase of positive
cells was observed. It is probable that the cell:cell contact
from HPASMCs and HPAECs could have resulted in the
high expression of collagen III observed in the endothelial
cells. Nevertheless, the observed augment of SMA+
HPAECs on those taking up HPASMC-EVs clearly shows
that these vesicles are able to promote phenotypic changes
in HPAECs under basal conditions. Since EVs show en-
richment in well-known mediators of EndoMT, the ob-
served increase points to an active contribution of EV-
mediated HPASMC-to-HPAEC communication in this
transition, which is critical for cardiovascular development
and homeostasis [33].
We then investigated if there is an enhancement in
this communication under pathological conditions, aim-
ing to modulate uptake by HPAECs using cytokines
found to increase in PAH: TGF-β1, BMP4, TNF-α, IL-1β
and VEGFA [5, 30, 31]. This validates our newly opti-
mised methodology for analysing the alteration of EV-
mediated transport in primary cell culture models. It is
known that IL1β and TNF-α are inflammatory. While
the former participates in the pathogenesis of some
forms of PAH [41], the latter contributes to it by inter-
acting with TGF-β signalling [42]. VEGFA is a central
cause for PAH development also found increased in dis-
eased lungs and alteration of the signalling pathway trig-
gered by its receptor using SU5416 is a widely used
PAH animal model [43]. Results showed increased up-
take and translation of EV-mRNA by both TGF-β1 and
(See figure on previous page.)
Fig. 6 EV-mediated transfer of mRNA from HPASMC to HPAECs is enhanced by TGF-β1 and IL-1β. a, Our primary cell Cre-loxP system was used
to analyse the alteration of uptake and translation of EV-mRNA by activated HPAECs in vitro. We analysed 5 cytokines related to PAH: TGF-β1 (5
ng/ml), BMP4 (5 ng/ml), IL-1β (5 ng/ml), TNF-α (1 ng/ml) and VEGFA (20 ng/ml). Stimuli were renewed every 48 h during the 7 days protocol. b,
Quantification of Cre-induced recombination by FACS showed significant differences in TGF-β1 and IL-1β treated HPASMC Cre+: HPAECs Rep+
co-cultures as compared to the untreated. c, NTA showed no alteration of release of EVs/cell to supernatant in HPASMCs treated with TGF-β1 and
IL-1β (both 10 ng/ml, 48 h and renewed every 24 h). d, Schematic representation of the biological relevance of the achieved results. Data are
presented as mean ± SEM. *P ≤ 0.05, **P≤ 0.01, ***P≤ 0.001 (Student’s t-test). All procedures were carried out with n = 3 biological replicates.
Scale bars 4x = 300 μm; 10x = 120 μm
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IL-1β stimulated HPAECs, since release of EVs by
HPASMC stimulated with these cytokines was found
unaffected. The observed enhancement of EV-mediated
HPASMCs:HPAECs communication with TGF-β1 and
IL-1β, together with the results that showed increase in
SMA, suggest that these EVs shall play a relevant role in
the transition of HPAECs into mesenchymal cells during
pulmonary hypertension development.
Since GDF11 has been reported to promote prolifera-
tion and abnormal angiogenesis on HPAECs [44] and
TGF-β3 to contribute to vascular remodelling occurring
during PAH [45], the enhanced EV uptake observed
might lead to functional changes in HPAECs towards a
PAH phenotype.
The hereby-described paracrine signalling, potentially
taking place in the pulmonary artery, point to both
TGF-β dependent and independent mechanisms, since
we show that HPASMC-EVs are able to induce a
phenotypic switch of HPAECS in basal conditions. The
contribution of TGF-β independent paracrine signalling
mechanisms in regulating fibrosis during PAH has been
already reported and HPAEC-EVs were shown to
mediate it [46]. It is therefore likely that these TGF-β
independent mechanisms play an important role in EV-
mediated communication within the pulmonary artery.
This would be the case for IL1-β, according to our re-
sults, in the same way that has been recently described
for aldosterone [46].
Conclusions
In summary, we have proven that HPAECs can take up
HPASMC-EVs and efficiently translate their mRNA
cargo. These EVs are enriched in Zeb1 and TGF-β
superfamily ligands and contribute to induce EndoMT
on HPAECs. The effects of HPASMC-EVs in healthy
HPAECs might be part of the physiological regulation of
TGF-β signalling and contribute to partial EndoMT,
which has been shown to promote angiogenesis [47] and
is critical for the cardiovascular system during develop-
ment [33, 48]. We have shown that activated HPAECs
increase uptake of HPASMC-EVs and therefore this
mechanism might as well contribute to PAH develop-
ment (Fig. 6d).
The results of these studies prove the biological rele-
vance of EV-mediated communication from HPASMC
to HPAECs and provide evidence of its potential role in
PAH development, paving the road for future in vivo
studies to examine their function further in physiological
and pathological conditions.
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